Learn More
Medchemexpress LLC 1,4-benzothiazepine, 2,3,4,5-tetrahydro-7-methoxy-4-methyl | 927871-76-9 | MFCD12546447 | 99.8% | 209.31 g·mol⁻¹ | C11H15NOS | 10 MG

Supplier: Medchemexpress LLC HY1529210MG
S107 is a small-molecule calstabin 2 modulator used in preclinical research. It is orally available and blood-brain barrier permeable, and stabilizes ryanodine receptor 2 (RyR2) channels by enhancing calstabin 2 binding. This mechanism reduces sarcoplasmic reticulum Ca2+ leak and has been evaluated in studies of cardiac arrhythmia and seizure threshold.
- Blood-brain barrier permeable.
- Stabilizes RyR2 channels by enhancing calstabin 2 binding.
- Reduces sarcoplasmic reticulum Ca2+ leak.
- Orally bioavailable in preclinical models.
- High purity solid suitable for research applications.
- Stable powder with recommended cold storage conditions.
- Well characterized chemically (formula C11H15NOS; MW 209.31 g·mol⁻¹).
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.